AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription
Molecular Therapy · 2024
DOI: 10.1016/j.ymthe.2024.09.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Hannah O Bazick und 4 weiteren Autor:innen. Beteiligte Einrichtung: UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, DNA, DNA Breaks, Double-Stranded. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NINDS NIH HHS, Simons Foundation Autism Research Initiative.
Abstract (Originalsprache)
We previously developed an adeno-associated virus (AAV) Cas9 gene therapy for Angelman syndrome that integrated into the genome and prematurely terminated Ube3a-ATS. Here, we assessed the performance of 3 additional AAV vectors containing S. aureus Cas9 in vitro and in vivo, and 25 vectors containing N. meningitidis Cas9 in vitro, all targeting single sites within Ube3a-ATS. We found that none of these single-target gRNA vectors were as effective as multi-target gRNA vectors at reducing Ube3a-ATS expression in neurons. We also developed an anchored multiplex PCR sequencing method and analysis pipeline to quantify the relative frequency of all possible editing events at target sites, including AAV integration and unresolved double-strand breaks. We found that integration of AAV was the most frequent editing event (67%-89% of all edits) at three different single target sites, surpassing insertions and deletions (indels). None of the most frequently observed indels were capable of blocking transcription when incorporated into a Ube3a-ATS minigene reporter, whereas two vector derived elements-the poly(A) and reverse promoter-reduced downstream transcription by up to 50%. Our findings suggest that the probability that a gene trapping AAV integration event occurs is influenced by which vector-derived element(s) are integrated and by the number of target sites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Carolina Institute for Developmental Disabilities, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Carolina Institute for Developmental Disabilities, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; D…
Förderung
- NICHD NIH HHS
- NINDS NIH HHS
- Simons Foundation Autism Research Initiative
- National Institute of Neurological Disorders and Stroke
- National Institute of Child Health and Human Development
- University of North Carolina
- Angelman Syndrome Foundation
- Simons Foundation
Zitieren
APA
Bazick, H. O., Mao, H., Niehaus, J. K., Wolter, J. M., & Zylka, M. J. (2024). AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2024.09.032
Vancouver
Bazick HO, Mao H, Niehaus JK, Wolter JM, Zylka MJ. AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2024.09.032
BibTeX
@article{Bazick2024,
author = {Bazick, Hannah O and Mao, Hanqian and Niehaus, Jesse K and Wolter, Justin M and Zylka, Mark J},
title = {AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription},
journal = {Molecular Therapy},
year = {2024},
doi = {10.1016/j.ymthe.2024.09.032}
}
EUVIMED